ADAMTSL3

Chr 15

ADAMTS like 3

Also known as: ADAMTSL-3

Predicted to be involved in extracellular matrix organization. Predicted to be active in extracellular matrix. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…
0
Active trials
7
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.65
LOEUF
DN
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.65LOEUF
pLI 0.000
Z-score 4.39
OE 0.51 (0.40–0.65)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.48Z-score
OE missense 0.96 (0.91–1.01)
917 obs / 958.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.51 (0.40–0.65)
0≤0.351.4
Missense OE?0.96 (0.91–1.01)
0≤0.61.4
Synonymous OE?0.98
0≤1.21.6
LoF obs/exp: 47 / 92.6Missense obs/exp: 917 / 958.4Syn Z: 0.29

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ADAMTSL3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →